KRAS and familial pancreatic carcinoma: PI3K can serve as an effector of activated K-Ras in pancreatic cancer cells (Prahallad et al, 2012; Eser et al, 2013) and K-Ras activity can modulate EGFR activation in colorectal cancer cells (Prahallad et al, 2012).